QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 187 filers reported holding QIAGEN NV in Q1 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $84,412,000 | -35.9% | 2,497,386 | -37.4% | 3.41% | -43.5% |
| Q3 2019 | $131,610,000 | -23.1% | 3,991,796 | -5.4% | 6.03% | -20.6% |
| Q2 2019 | $171,093,000 | -2.5% | 4,219,305 | -2.2% | 7.58% | -1.5% |
| Q1 2019 | $175,444,000 | +15.6% | 4,312,772 | -2.1% | 7.70% | -1.9% |
| Q4 2018 | $151,824,000 | -4.1% | 4,407,084 | +5.5% | 7.86% | +15.2% |
| Q3 2018 | $158,235,000 | +16.4% | 4,177,260 | +11.1% | 6.82% | +18.8% |
| Q2 2018 | $135,902,000 | +15.2% | 3,758,339 | +2.9% | 5.74% | +14.5% |
| Q1 2018 | $117,976,000 | +6.5% | 3,651,379 | +2.0% | 5.02% | +7.0% |
| Q4 2017 | $110,728,000 | -2.5% | 3,579,954 | -0.7% | 4.69% | -3.3% |
| Q3 2017 | $113,620,000 | -6.2% | 3,606,995 | -0.2% | 4.85% | -7.2% |
| Q2 2017 | $121,126,000 | +17.0% | 3,612,479 | +1.1% | 5.23% | +12.4% |
| Q1 2017 | $103,519,000 | – | 3,573,334 | – | 4.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
| Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
| Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
| Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
| RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
| SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
| FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
| Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
| Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |